The Europe latent TB detection market is expected to grow from US$ 304.39 million in 2020 to US$ 420.88 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027.
The UK, Germany, France, Italy, and Spain are major economies in Europe. Rising government initiatives to promote tuberculosis detection is expected to surge the market growth. The disease disproportionally affects the poor, vulnerable, undernourished, and marginalized people. Evidence from various sources such as World Health Organization (WHO) and the United Nations (UN) shows that countries such as Germany and the UK are highly populated with patients suffering from TB. Thus, the government bodies in these countries are undertaking and adopting certain schemes and initiatives in containing the disease. Furthermore, countries of the Europe region are giving significant importance in combating TB by undertaking various funding programs. The UK government is one of the largest donor of the Global Fund to fight AIDS, tuberculosis, and malaria. Thus, the financial and medical assistance from the governments for fighting the disease and promoting the diagnosis of TB is providing a lucrative scenario for the growth of the Europe market.In case of COVID-19, Europe is highly affected specially France followed by Spain, Italy, and Germany. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than they were during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain and Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity, which is restricting the growth of the market. The COVID-19 pandemic and associated response have impacted healthcare services globally, severely disrupting care for many communicable diseases such as tuberculosis TB. Laboratory diagnostic services, considered a cornerstone of any country's capacity to manage TB, are likely to be severely impacted by the COVID-19 pandemic due to re-allocation of resources. In England, compared with 2019, TB notifications decreased by 16.5% during April and by 37.3% during May 2020; the LTBI program was paused in response to COVID-19 in March.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe latent TB detection market. The Europe latent TB detection market is expected to grow at a good CAGR during the forecast period. 
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Latent TB Detection Market Segmentation
Europe Latent TB Detection Market – By Test
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
Europe Latent TB Detection Market – By End User
- Hospitals
- Diagnostic Centers
- Laboratories
- Others
Europe Latent TB Detection Market, by Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Latent TB Detection Market -Companies Mentioned
- Abbott
- ARKRAY, Inc.
- BD
- bioMerieux SA
- F. HOFFMANN-LA ROCHE LTD.
- Lionex GmbH
- Oxford Immunotec Ltd
- QIAGEN
- Serum Institute of India Pvt. Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test and Interferon Gamma Released Assay and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Latent TB Detection Market – By Test
1.3.2 Europe Latent TB Detection Market – By End User
1.3.3 Europe Latent TB Detection Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Latent TB Detection Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
5. Europe Latent TB Detection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Tuberculosis
5.1.2 Rising Government Initiatives to Promote Tuberculosis Detection
5.2 Market Restraints
5.2.1 Existance of Multidrug Resistant Tuberculosis (MDR-TB)
5.3 Market Opportunities
5.3.1 Rise of Market in Emerging Economies
5.4 Future Trends
5.4.1 Surging Advancements in Tuberculosis Diagnosis
5.5 Impact Analysis
6. Latent TB Detection Market – Europe Analysis
6.1 Europe Latent TB Detection Market Revenue Forecast and Analysis
7. Europe Latent TB Detection Market Analysis – By Test
7.1 Overview
7.2 Europe Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
7.4 Tuberculin Skin Test (TST)
7.4.1 Overview
7.4.2 Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Interferon Gamma Released Assay (IGRA)
7.5.1 Overview
7.5.2 Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8. Europe Latent TB Detection Market Analysis – By End User
8.1 Overview
8.2 Europe Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
8.4 Hospitals
8.4.1 Overview
8.4.2 Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.5 Diagnostic Centers
8.5.1 Overview
8.5.2 Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.6 Laboratories
8.6.1 Overview
8.6.2 Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
9. Europe Latent TB Detection Market Analysis and Forecasts To 2027 – Country Analysis
9.1 Europe: Latent TB Detection Market
9.1.1 Overview
9.1.3 Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)
9.1.4 Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.1 Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.2 Germany: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.4.3 Germany: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.5 UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1 UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 UK: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.5.3 UK: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.6 France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 France: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 France: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.7 Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Italy: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Italy: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.8 Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Spain: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Spain: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Europe Latent TB Detection Market
10.1 Europe: Impact Assessment Of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 QIAGEN
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bioMerieux SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Oxford Immunotec Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Lionex GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ARKRAY, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Serum Institute of India Pvt. Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Latent TB Detection Market – Revenue, and Forecast to 2027 (US$ Million)
Table 2. Germany: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 3. Germany: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. UK: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 5. UK: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. France: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 7. France: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 8. Italy: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 9. Italy: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Spain: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 11. Spain: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 12. Organic Developments Done By Companies
Table 13. Inorganic Developments Done By Companies
Table 14. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Latent TB Detection Market Segmentation
Figure 2. Europe Latent TB Detection Market – By Country
Figure 3. Europe Latent TB Detection Market Overview
Figure 4. Interferon Gamma Released Assay (IGRA) Segment Held Largest Share of Europe Latent TB Detection Market
Figure 5. Germany to Show Remarkable Growth During Forecast Period
Figure 7. Europe PEST Analysis
Figure 8. Europe Latent TB Detection Market Impact Analysis of Drivers and Restraint
Figure 9. Europe Latent TB Detection Market – Revenue Forecast and Analysis
Figure 10. Europe Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
Figure 11. Europe Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Europe Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Europe Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
Figure 14. Europe Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Europe Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Europe Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. Europe Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Europe: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)
Figure 19. Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)
Figure 20. Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 21. UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Impact of COVID-19 Pandemic in European Country Markets
- Abbott
- ARKRAY, Inc.
- BD
- bioMerieux SA
- F. HOFFMANN-LA ROCHE LTD.
- Lionex GmbH
- Oxford Immunotec Ltd
- QIAGEN
- Serum Institute of India Pvt. Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Latent TB Detection Market
Sep 2021
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Sep 2021
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Sep 2021
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Sep 2021
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Sep 2021
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Sep 2021
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Sep 2021
Infusion Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Infusion Pumps Pumps [Volumetric Pumps, Syringe Pumps, Insulin Pumps, Patient Control Analgesia (PCA) Pumps, Enteral Pumps, Implantable Pumps, and Elastomeric Pumps] and Infusion Sets [Vented Infusion Sets and Non-Vented Infusion Sets], Application (Diabetes, Oncology, Pain Management, Hematology, Pediatrics, Gastroenterology, and Others), End User (Hospitals and Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), and Geography
Sep 2021
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For